Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 17-Jun-22 4:58 PM View:  | Allogene Therapeutics, Inc. (ALLO) | 15-Jun-22 | Grant | 44,178 | -- | -- | 17% 258.88K to 303.06K | |
| 09-Mar-22 6:26 PM View: | Allogene Therapeutics, Inc. (ALLO) | 07-Mar-22 | Gift | 412,618 | -- | -- | (61%) 671.5K to 258.88K | |
| 09-Mar-22 6:26 PM View: | Allogene Therapeutics, Inc. (ALLO) | 07-Mar-22 | Acquisition (other) | 412,618 | -- | -- | 159% 258.88K to 671.5K | |
| 09-Mar-22 4:40 PM View: | Kronos Bio, Inc. (KRON) | 07-Mar-22 | Gift | 211,000 | -- | -- | 223% 94.48K to 305.48K | |
| 09-Mar-22 4:40 PM View: | Kronos Bio, Inc. (KRON) | 07-Mar-22 | Gift | 211,000 | -- | -- | (69%) 305.48K to 94.48K | |
| 14-Jan-22 2:13 PM View: | Allogene Therapeutics, Inc. (ALLO) | 12-Jan-22 | Market Purchase | 15,000 | $12.60 | $189,000.00 | 6% 243.88K to 258.88K | (3%) |
| 11-Jun-21 5:43 PM View: | Allogene Therapeutics, Inc. (ALLO) | 11-Jun-21 | Gift | 500,000 | -- | -- | (67%) 743.88K to 243.88K | |
| 11-Jun-21 5:43 PM View: | Allogene Therapeutics, Inc. (ALLO) | 10-Jun-21 | Grant | 16,498 | -- | -- | 2% 727.39K to 743.88K | |
| 07-Jun-21 6:39 PM View: | Latch, Inc. (LTCH) | 04-Jun-21 | Option Exercise | 30,000 | -- | -- | 100% 0 to 30.0K | |
| 16-Feb-21 6:03 PM View: | Tishman Speyer Innovation C... (TSIB) | 12-Feb-21 | Purchase | 25,000 | -- | -- | 100% 0 to 25.0K | |
| 03-Feb-21 10:00 PM View: | Allogene Therapeutics, Inc. (ALLO) | 21-Oct-20 | Gift | 305,918 | -- | -- | (30%) 1.03M to 727.39K | |
| 16-Oct-20 3:47 PM View: | Kronos Bio, Inc. (KRON) | 14-Oct-20 | Conversion | 92,371 | -- | -- | 333% 27.78K to 120.15K | |
| 09-Jun-20 4:04 PM View: | Allogene Therapeutics, Inc. (ALLO) | 05-Jun-20 | Grant | 9,969 | -- | -- | < 1% 1.02M to 1.03M | |
| 28-Apr-20 4:33 PM View: | Allogene Therapeutics, Inc. (ALLO) | 24-Apr-20 | Acquisition (other) | 8,039 | -- | -- | < 1% 1.02M to 1.02M | |
| 11-Mar-20 4:39 PM View: | Allogene Therapeutics, Inc. (ALLO) | 04-Mar-20 | Acquisition (other) | 8,217 | -- | -- | < 1% 1.01M to 1.02M | |
| 21-Nov-19 4:43 PM View: | Allogene Therapeutics, Inc. (ALLO) | 19-Nov-19 | Acquisition (other) | 8,217 | -- | -- | < 1% 1.45M to 1.45M | |
| 21-Nov-19 4:43 PM View: | Allogene Therapeutics, Inc. (ALLO) | 11-Nov-19 | Gift | 446,623 | -- | -- | (31%) 1.45M to 1.01M | |
| 29-Oct-19 8:07 PM View: | Allogene Therapeutics, Inc. (ALLO) | 25-Oct-19 | Acquisition (other) | 8,217 | -- | -- | < 1% 1.44M to 1.45M | |
| 25-Sep-19 6:24 PM View: | Allogene Therapeutics, Inc. (ALLO) | 23-Sep-19 | Acquisition (other) | 8,217 | -- | -- | < 1% 1.43M to 1.44M | |
| 09-Sep-19 6:02 PM View: | Allogene Therapeutics, Inc. (ALLO) | 05-Sep-19 | Acquisition (other) | 8,217 | -- | -- | < 1% 1.42M to 1.43M | |
| 22-Jul-19 4:26 PM View: | Allogene Therapeutics, Inc. (ALLO) | 18-Jul-19 | Acquisition (other) | 8,217 | -- | -- | < 1% 1.41M to 1.42M | |
| 12-Jul-19 5:11 PM View: | Allogene Therapeutics, Inc. (ALLO) | 10-Jul-19 | Acquisition (other) | 5,590 | -- | -- | < 1% 1.41M to 1.41M | |
| 24-Jun-19 8:02 PM View: | Allogene Therapeutics, Inc. (ALLO) | 06-Jun-19 | Grant | 16,377 | -- | -- | 1% 1.39M to 1.41M | |
| 05-Mar-19 5:42 PM View: | Target Hospitality Corp. (TH) | 05-Mar-19 | Market Purchase | 5,000 | $10.20 | $51,000.00 | 100% 5.0K to 10.0K | (84%) |
| 01-Mar-19 7:21 PM View: | Target Hospitality Corp. (TH) | 01-Mar-19 | Market Purchase | 5,000 | $10.13 | $50,650.00 | 100% 0 to 5.0K | (84%) |
| 17-Oct-18 5:31 PM View: | Allogene Therapeutics, Inc. (ALLO) | 15-Oct-18 | Conversion | 18,716 | -- | -- | 1% 1.37M to 1.39M | |
| 14-Feb-18 10:00 PM View: | Nile Therapeutics, Inc (CAPR) | 27-Dec-17 | Gift | 17,786 | -- | -- | (34%) 52.67K to 34.88K | |
| 14-Feb-18 10:00 PM View: | Nile Therapeutics, Inc (CAPR) | 26-Dec-17 | Gift | 1,000 | -- | -- | (2%) 53.67K to 52.67K | |
| 05-Oct-17 8:25 PM View: | Kite Pharma, Inc. (KITE) | 03-Oct-17 | Disposition | 70,050 | $180.00 | $12,609,000.00 | (94%) 74.41K to 4.36K | |
| 05-Oct-17 8:25 PM View: | Kite Pharma, Inc. (KITE) | 03-Oct-17 | Disposition | 1,807 | -- | -- | (41%) 4.36K to 2.55K | |
| 05-Oct-17 8:25 PM View: | Kite Pharma, Inc. (KITE) | 03-Oct-17 | Disposition (change in control) | 2,553 | $180.00 | $459,540.00 | (100%) 2.55K to 0 | |
| 05-Oct-17 8:25 PM View: | Kite Pharma, Inc. (KITE) | 28-Sep-17 | Acquisition (other) | 70,050 | -- | -- | 1607% 4.36K to 74.41K | |
| 22-Jun-17 2:38 PM View: | Kite Pharma, Inc. (KITE) | 20-Jun-17 | Grant | 2,410 | -- | -- | 124% 1.95K to 4.36K | |
| 14-Feb-17 10:00 PM View: | Kite Pharma, Inc. (KITE) | 28-Sep-16 | Gift | 215,000 | -- | -- | (99%) 216.95K to 1.95K | |
| 03-Jun-16 7:12 PM View: | Kite Pharma, Inc. (KITE) | 01-Jun-16 | Grant | 1,950 | -- | -- | < 1% 215.0K to 216.95K | |
| 12-Feb-16 4:46 PM View: | Kite Pharma, Inc. (KITE) | 20-Nov-15 | Gift | 100,000 | -- | -- | (32%) 315.0K to 215.0K | |
| 12-Feb-16 4:46 PM View: | Kite Pharma, Inc. (KITE) | 12-Nov-15 | Gift | 12,500 | -- | -- | (4%) 327.5K to 315.0K | |
| 12-Feb-16 4:46 PM View: | Kite Pharma, Inc. (KITE) | 31-Mar-15 | Gift | 110,000 | -- | -- | (25%) 437.5K to 327.5K | |
| 22-Jan-15 7:25 PM View: | Nile Therapeutics, Inc (CAPR) | 21-Jan-15 | Private Purchase | 7,096 | $3.52 | $24,999.20 | 14% 49.88K to 56.98K | |
| 28-Jan-14 5:10 PM View: | Nile Therapeutics, Inc (CAPR) | 20-Nov-13 | Acquisition (other) | 1,875 | -- | -- | 4% 48.01K to 49.88K | |
| 28-Jan-14 5:10 PM View: | Nile Therapeutics, Inc (CAPR) | 13-Nov-13 | Acquisition (other) | 50 | -- | -- | < 1% 47.96K to 48.01K | |
| 02-Apr-12 3:27 PM View: | Nile Therapeutics, Inc (CAPR) | 30-Mar-12 | Purchase | 125,000 | -- | -- | 5% 2.27M to 2.4M | |
| 26-Apr-10 2:25 PM View: | Nile Therapeutics, Inc (CAPR) | 22-Apr-10 | Purchase | 50,000 | -- | -- | 2% 2.22M to 2.27M | |
| 09-Jul-09 5:42 PM View: | Nile Therapeutics, Inc (CAPR) | 07-Jul-09 | Purchase | 197,628 | -- | -- | 10% 2.03M to 2.22M | |
| 13-Mar-09 7:45 PM View: | Nile Therapeutics, Inc (CAPR) | 12-Mar-09 | Purchase | 510 | $0.75 | $382.50 | < 1% 1.86M to 1.86M | 17% |
| 16-Dec-08 9:29 PM View: | Nile Therapeutics, Inc (CAPR) | 16-Dec-08 | Market Purchase | 3,100 | $1.15 | $3,565.00 | < 1% 1.86M to 1.86M | (100%) |
| 15-Dec-08 8:51 PM View: | Nile Therapeutics, Inc (CAPR) | 15-Dec-08 | Market Purchase | 2,500 | $1.05 | $2,625.00 | < 1% 1.85M to 1.86M | (100%) |
| 12-Dec-08 7:25 PM View: | Nile Therapeutics, Inc (CAPR) | 12-Dec-08 | Market Purchase | 4,100 | $1.44 | $5,907.28 | < 1% 1.85M to 1.85M | (100%) |
| 12-Dec-08 7:25 PM View: | Nile Therapeutics, Inc (CAPR) | 11-Dec-08 | Market Purchase | 4,100 | $0.82 | $3,376.76 | < 1% 1.85M to 1.85M | (100%) |
| 05-Apr-05 4:35 PM View: | Manhattan Pharmaceuticals I... (TGTX) | 01-Apr-05 | Grant | 248,827 | -- | -- | 102% 244.03K to 492.85K |